Drugs News and Research

RSS

Lifetime risk of death from firearms, drug overdoses is substantial in the United States

A new study appearing in The American Journal of Medicine, published by Elsevier, calculates the lifetime risk of death from firearms and drug overdoses in the United States.

19 Aug 2020

Research makes a leap forward in understanding how the skin heals

People who suffer severe burns or extensive skin injuries are often left to live with extreme scarring, disfigurement, and skin that feels chronically tight and itchy.

19 Aug 2020

UIC's first-of-its-kind contraceptive receives FDA approval

A first-of-its-kind contraceptive developed at the University of Illinois Chicago has been approved by the U.S. Food and Drug Administration.

19 Aug 2020

Researchers identify drug that improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically ill patients admitted to the intensive care unit.

19 Aug 2020

New approach to chronic pain treatment could bring relief

Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain - for example, the feeling after hitting your finger with a hammer - chronic pain may not even have a clear cause, and it can linger for years or lifetimes.

19 Aug 2020

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

In 2018 and 2019, the German Institute for Quality and Efficiency in Health Care already investigated whether the drug enzalutamide has an advantage in comparison with the appropriate comparator therapy, i.e. in comparison with watchful waiting while maintaining ongoing conventional androgen deprivation therapy (ADT), for adult men with high-risk non-metastatic castration-resistant prostate cancer.

19 Aug 2020

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Australian researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to immunotherapy using models of the disease.

19 Aug 2020

Microbial diversity can improve treatment for cancer patients

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens.

19 Aug 2020

Mathematical modeling helps researchers track and tackle COVID-19 pandemic

The Editor-in-Chief Vitaly Volpert of the Institut Camille Jordan, University ofLyon, France, reviews how the public's new favourite scientific discipline, mathematical modelling, is being used to track and tackle the COVID-19 pandemic.

19 Aug 2020

Gut microbiome may play a part in severe COVID-19

A recent study published on the preprint medRxiv* in August 2020 reports on the evidence that the gut microbiome may play a part in severe COVID-19 infection.

19 Aug 2020

CARE consortium launches to accelerate drug discovery and development for COVID-19

CARE a new consortium supported by the Innovative Medicines Initiative public-private partnership announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.

19 Aug 2020

Study identifies key gene as future therapeutic target for aggressive endometrial cancer

A new study has identified a key gene in aggressive endometrial cancer, which could lead to a targeted therapeutic strategy to improve survival rates.

19 Aug 2020

Study fills crucial knowledge gaps on myasthenia gravis

A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle.

19 Aug 2020

Drugs News and Research

Lifetime risk of death from firearms, drug overdoses is substantial in the United States

Research makes a leap forward in understanding how the skin heals

UIC's first-of-its-kind contraceptive receives FDA approval

Researchers identify drug that improves survival in critically ill COVID-19 patients

New approach to chronic pain treatment could bring relief

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Microbial diversity can improve treatment for cancer patients

Mathematical modeling helps researchers track and tackle COVID-19 pandemic

Gut microbiome may play a part in severe COVID-19

CARE consortium launches to accelerate drug discovery and development for COVID-19

Study identifies key gene as future therapeutic target for aggressive endometrial cancer

Study fills crucial knowledge gaps on myasthenia gravis

Antidepressants are not designed for dementia, shows study

Study shows how common drug paralyzes the parasites that cause elephantiasis

Study provides clues to why age is a major risk factor for COVID-19 patients

RNA-based therapeutic approach holds promise as potential cure for hereditary diseases

Manipulating cancer cell metabolism may help combat DIPGs and other brain tumors

Calcified plaque in the arteries better predicts future heart attacks than strokes

Researchers identify shared molecular roots between lipid dysfunction and autism

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News